Ticker
IBIOCompany Name
IBIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 8.79M | 1.44 | $ 6.11M |
3/31/2025 | $ 5.18M | 0.96 | $ 5.4M |
12/31/2024 | $ 7.24M | 1.54 | $ 4.71M |
9/30/2024 | $ 11.26M | 3.25 | $ 3.47M |
6/30/2024 | $ 14.43M | 3.76 | $ 3.84M |
3/31/2024 | $ 6.43M | 0.3 | $ 21.43M |
12/31/2023 | $ 4.06M | 0.19 | $ 21.55M |
9/30/2023 | $ 4.76M | 0.23 | $ 20.71M |
6/30/2023 | $ 7.58M | 0.35 | $ 21.58M |
3/31/2023 | $ 9.81M | 0.44 | $ 22.28M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for IBIO INC is calculated as follows: CashnEq [ $ 77.54M ] / LiabilitesC [ $ 5.05M ]
(=) Cash Ratio [ 15.37 ]
Minimum
Dec 31, 2022
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |